Effect of recombinant human bone morphogenetic protein 2 associated with a variety of bone substitutes on vertical guided bone regeneration in rabbit calvarium

Journal of Periodontology

Volumn 84, Issue 3, 2013, Pages 360-370

  Polo, Cristiane Ibanhes ^a,b   Lima, Júlio Leonardo Oliveira ^a,b   De Lucca, Leandro ^b   Piacezzi, Christiano Borges ^b   Naclério Homem, Maria Da Graça ^a   Arana Chavez, Victor Elias ^a   Sendyk, Wilson Roberto ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Santo Amaro University   (Brazil)

Author keywords

Biocompatible materials; Bone morphogenetic protein 2; Bone regeneration; Bone substitutes; Calcium phosphates; Osteogenesis

Indexed keywords

BETA-TRICALCIUM PHOSPHATE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM PHOSPHATE; HYDROXYAPATITE; HYDROXYAPATITE BETA TRICALCIUM PHOSPHATE; HYDROXYAPATITE-BETA TRICALCIUM PHOSPHATE; RECOMBINANT PROTEIN;

ANIMAL; ARTICLE; BONE PROSTHESIS; BONE REGENERATION; DRUG EFFECT; METHODOLOGY; RABBIT; SKULL; TISSUE REGENERATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; BONE SUBSTITUTES; CALCIUM PHOSPHATES; GUIDED TISSUE REGENERATION; HYDROXYAPATITES; RABBITS; RECOMBINANT PROTEINS; SKULL;

EID: 84874588955     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.110674     Document Type: Article

References (54)

1. Hollister MC, Weintraub JA. The association of oral status with systemic health, quality of life, and economic productivity. J Dent Educ 1993;57: 901-912.
2. von Arx T, Cochran DL, Hermann JS, Schenk RK, Higginbottom FL, Buser D. Lateral ridge augmentation and implant placement: An experimental study evaluating implant osseointegration in different augmentation materials in the canine mandible. Int J Oral Maxillofac Implants 2001;16: 343-354. (Pubitemid 33673137)
3. Schmitt CM, Doering H, Schmidt T, Lutz R, Neukam FW, Schlegel KA. Histological results after maxillary sinus augmentation with Straumann- BoneCeramic, Bio-Oss-, Puros-, and autologous bone. A randomized controlled clinical trial [published online ahead of print February 13, 2012]. Clin Oral Implants Res. doi: 10.1111/j.1600-0501.2012.02431.x.
4. Nampo T, Watahiki J, Enomoto A, et al. A new method for alveolar bone repair using extracted teeth for the graft material. J Periodontol 2010;81: 1264-1272.
5. Kalk WW, Raghoebar GM, Jansma J, Boering G. Morbidity from iliac crest bone harvesting. J Oral Maxillofac Surg 1996;54: 1424-1429, discussion 1430. (Pubitemid 27106138)
6. Raghoebar GM, Meijndert L, Kalk WW, Vissink A. Morbidity of mandibular bone harvesting: A comparative study. Int J Oral Maxillofac Implants 2007;22: 359-365.
7. Urist MR. Bone: Formation by autoinduction. Science 1965;150: 893-899.
8. Jensen SS, Aaboe M, Pinholt EM, Hjørting-Hansen E, Melsen F, Ruyter IE. Tissue reaction and material characteristics of four bone substitutes. Int J Oral Maxillofac Implants 1996;11: 55-66. (Pubitemid 126442754)
9. Ripamonti U, Tasker Jr. Advances in biotechnology for tissue engineering of bone. Curr Pharm Biotechnol 2000;1: 47-55.
10. Yuan H, Fernandes H, Habibovic P, et al. Osteoinductive ceramics as a synthetic alternative to autologous bone grafting. Proc Natl Acad Sci USA 2010;107: 13614-13619.
11. Habibovic P, Kruyt MC, Juhl MV, et al. Comparative in vivo study of six hydroxyapatite-based bone graft substitutes. J Orthop Res 2008;26: 1363-1370.
12. Yang RN, Ye F, Cheng LJ, et al. Osteoinduction by Ca-P biomaterials implanted into the muscles of mice. J Zhejiang Univ Sci B 2011;12: 582-590.
13. LeGeros RZ, Lin S, Rohanizadeh R, Mijares D, LeGeros JP. Biphasic calcium phosphate bioceramics: Preparation, properties and applications. J Mater Sci Mater Med 2003;14: 201-209. (Pubitemid 36408019)
14. Simunek A, Kopecka D, Somanathan RV, Pilathadka S, Brazda T. Deproteinized bovine bone versus betatricalcium phosphate in sinus augmentation surgery: A comparative histologic and histomorphometric study. Int J Oral Maxillofac Implants 2008;23: 935-942.
15. Matsushita N, Terai H, Okada T, et al. Accelerated repair of a bone defect with a synthetic biodegradable bone-inducing implant. J Orthop Sci 2006;11: 505-511. (Pubitemid 44496660)
16. Maus U, Andereya S, Gravius S, Ohnsorge JA, Niedhart C, Siebert CH. BMP-2 incorporated in a tricalcium phosphate bone substitute enhances bone remodeling in sheep. J Biomater Appl 2008;22: 559-576. (Pubitemid 351597408)
17. Lindgren C, Hallman M, Sennerby L, Sammons R. Back-scattered electron imaging and elemental analysis of retrieved bone tissue following sinus augmentation with deproteinized bovine bone or biphasic calcium phosphate. Clin Oral Implants Res 2010;21: 924-930.
18. Komlev VS, Mastrogiacomo M, Pereira RC, Peyrin F, Rustichelli F, Cancedda R. Biodegradation of porous calcium phosphate scaffolds in an ectopic bone formation model studied by X-ray computed microtomograph. Eur Cell Mater 2010;19: 136-146.
19. Por YC, Barceló CR, Salyer KE, et al. Bone generation in the reconstruction of a critical size calvarial defect in an experimental model. J Craniofac Surg 2008;19: 383-392. (Pubitemid 351521674)
20. Urist MR, Strates BS. Bone morphogenetic protein. J Dent Res 1971;50: 1392-1406.
21. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: Molecular clones and activities. Science 1988;242: 1528-1534. (Pubitemid 19023695)
22. Wozney JM, Rosen V, Byrne M, Celeste AJ, Moutsatsos I, Wang EA. Growth factors influencing bone development. J Cell Sci Suppl 1990;13: 149-156.
23. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990;87: 2220-2224.
24. Celeste AJ, Iannazzi JA, Taylor RC, et al. Identification of transforming growth factor b family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990;87: 9843-9847. (Pubitemid 120016540)
25. Rosen V, Thies RS. The BMP proteins in bone formation and repair. Trends Genet 1992;8: 97-102.
26. Lee MB. Bone morphogenetic proteins: Background and implications for oral reconstruction. A review. J Clin Periodontol 1997;24: 355-365. (Pubitemid 127731535)
27. Boyne PJ, Marx RE, Nevins M, et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation. Int J Periodontics Restorative Dent 1997;17: 11-25. (Pubitemid 127499619)
28. Cheng H, Jiang W, Phillips FM, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 2003; 85-A: 1544-1552. (Pubitemid 36951140)
29. Gutwald R, Haberstroh J, Stricker A, et al. Influence of rhBMP-2 on bone formation and osseointegration in different implant systems after sinus-floor elevation. An in vivo study on sheep. J Craniomaxillofac Surg 2010;38: 571-579.
30. Cochran DL, Nummikoski PV, Jones AA, Makins SR, Turek TJ, Buser D. Radiographic analysis of regenerated bone around endosseous implants in the canine using recombinant human bone morphogenetic protein-2. Int J Oral Maxillofac Implants 1997;12: 739-748. (Pubitemid 127500134)
31. Cochran DL, Jones AA, Lilly LC, Fiorellini JP, Howell H. Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans. J Periodontol 2000;71: 1241-1257.
32. Jung RE, Windisch SI, Eggenschwiler AM, Thoma DS, Weber FE, Hämmerle CH. A randomized-controlled clinical trial evaluating clinical and radiological outcomes after 3 and 5 years of dental implants placed in bone regenerated by means of GBR techniques with or without the addition of BMP-2. Clin Oral Implants Res 2009;20: 660-666.
33. Wikesjö UME, Huang YH, Xiropaidis AV, et al. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates. J Clin Periodontol 2008;35: 992-1000.
34. Decker JF, Lee J, Cortella CA, et al. Evaluation of implants coated with recombinant human bone morphogenetic protein-2 and vacuum-dried using the critical-size supraalveolar peri-implant defect model in dogs. J Periodontol 2010;81: 1839-1849.
35. Fiorellini JP, Buser D, Riley E, Howell TH. Effect on bone healing of bone morphogenetic protein placed in combination with endosseous implants: A pilot study in beagle dogs. Int J Periodontics Restorative Dent 2001; 21: 41-47. (Pubitemid 33743253)
36. Jung RE, Weber FE, Thoma DS, Ehrbar M, Cochran DL, Hämmerle CH. Bone morphogenetic protein-2 enhances bone formation when delivered by a synthetic matrix containing hydroxyapatite/tricalciumphosphate. Clin Oral Implants Res 2008;19: 188-195.
37. Wikesjö UM, Qahash M, Thomson RC, et al. rhBMP-2 significantly enhances guided bone regeneration. Clin Oral Implants Res 2004;15: 194-204. (Pubitemid 40109804)
38. Sigurdsson TJ, Nygaard L, Tatakis DN, et al. Periodontal repair in dogs: Evaluation of rhBMP-2 carriers. Int J Periodontics Restorative Dent 1996;16: 524-537.
39. Boyne PJ. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects. J Bone Joint Surg Am 2001;83-A (Suppl. 1):S146-S150.
40. Schmid J, Hämmerle CH, Olah AJ, Lang NP. Membrane permeability is unnecessary for guided generation of new bone. An experimental study in the rabbit. Clin Oral Implants Res 1994;5: 125-130.
41. Slotte C, Lundgren D, Burgos PM. Placement of autogeneic bone chips or bovine bone mineral in guided bone augmentation: A rabbit skull study. Int J Oral Maxillofac Implants 2003;18: 795-806. (Pubitemid 38032642)
42. Pelegrine AA, Sorgi da Costa CE, Sendyk WR, Gromatzky A. The comparative analysis of homologous fresh frozen bone and autogenous bone graft, associated or not with autogenous bone marrow, in rabbit calvaria: A clinical and histomorphometric study. Cell Tissue Bank 2011;12: 171-184.
43. Schmid J, Wallkamm B, Hämmerle CH, Gogolewski S, Lang NP. The significance of angiogenesis in guided bone regeneration. A case report of a rabbit experiment. Clin Oral Implants Res 1997;8: 244-248. (Pubitemid 127688460)
44. Yamada Y, Tamura T, Hariu K, Asano Y, Sato S, Ito K. Angiogenesis in newly augmented bone observed in rabbit calvarium using a titanium cap. Clin Oral Implants Res 2008;19: 1003-1009.
45. Kruyt MC, Delawi D, Habibovic P, Oner FC, van Blitterswijk CA, Dhert WJ. Relevance of bone graft viability in a goat transverse process model. J Orthop Res 2009;27: 1055-1059.
46. Neter J, Kutner MH, Nachtsheim CJ, Li W. Applied Linear Statistical Models, 5th ed. Chicago: Irwin; 2005.
47. Linde A, Thorén C, Dahlin C, Sandberg E. Creation of new bone by an osteopromotive membrane technique: An experimental study in rats. J Oral Maxillofac Surg 1993;51: 892-897. (Pubitemid 23237082)
48. Lundgren AK, Lundgren D, Hämmerle CH, Nyman S, Sennerby L. Influence of decortication of the donor bone on guided bone augmentation. An experimental study in the rabbit skull bone. Clin Oral Implants Res 2000;11: 99-106.
49. Kostopoulos L, Karring T, Uraguchi R. Formation of jawbone tuberosities by guided tissue regeneration. An experimental study in the rat. Clin Oral Implants Res 1994;5: 245-253.
50. Nishimura I, Shimizu Y, Ooya K. Effects of cortical bone perforation on experimental guided bone regeneration. Clin Oral Implants Res 2004;15: 293-300. (Pubitemid 40340570)
51. Erben RG. Bone labeling techniques. In: Yuehuei HA, Kylie LM, eds. Handbook of Histology Methods for Bone and Cartilage. Totowa, NJ: Humana Press; 2003: 99-117.
52. Barboza EP, Caú la AL, Caú la FdeO, et al. Effect of recombinant human bone morphogenetic protein-2 in an absorbable collagen sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defects. J Periodontol 2004;75: 702-708.
53. Miranda DA, Blumenthal NM, Sorensen RG, Wozney JM, Wikesjö UM. Evaluation of recombinant human bone morphogenetic protein-2 on the repair of alveolar ridge defects in baboons. J Periodontol 2005;76: 210-220. (Pubitemid 40542248)
54. U.S. Food and Drug Administration. INFUSE Bone Graft - P050053. Device Approvals and Clearances. Available at: http://www.fda.gov/MedicalDevices/ ProductsandMedicalProcedures/DeviceApprovalsand Clearances/Recently- ApprovedDevices/ucm081154. htm. Accessed April 1, 2012.